Loading insider details...
Beta
Latest Form 4 (Sep 11, 2026): Grant/Award of 76,080 WHWK shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 11, 2026 | Whitehawk Therapeutics, Inc. (WHWK) | Grant/Award | 76,080 | n/a |
| Jul 17, 2025 | INCYTE CORP (INCY) | Sale | 983 | $67.2K |
| Jul 16, 2025 | INCYTE CORP (INCY) | Tax Withholding | 595 | $41.6K |
| Jul 7, 2025 | INCYTE CORP (INCY) | Tax Withholding | 6,809 | $464.2K |
| Apr 3, 2025 | INCYTE CORP (INCY) | Grant/Award | 11,159 | n/a |
| Jan 22, 2025 | INCYTE CORP (INCY) | Grant/Award | 14,772 | n/a |
| Dec 3, 2024 | INCYTE CORP (INCY) | Sale | 360 | $27.2K |
| Jul 29, 2024 | INCYTE CORP (INCY) | Sale | 15,571 | $1.09M |
| Jul 17, 2024 | INCYTE CORP (INCY) | Grant/Award | 7,278 | n/a |
| Jul 3, 2024 | INCYTE CORP (INCY) | Tax Withholding | 5,706 | $336.8K |